These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 7037178

  • 21. [Indirect endolymphatic chemotherapy of patients with lymphoma].
    Kindzel'skiĭ LP, Gubareva AA.
    Vrach Delo; 1989 Jun; (6):64-6. PubMed ID: 2781767
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
    De Vita VT, Hubbard SM, Longo DL.
    Cancer Res; 1987 Nov 15; 47(22):5810-24. PubMed ID: 3311358
    [No Abstract] [Full Text] [Related]

  • 25. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL, Duffey PL, Gribben JG, Jaffe ES, Curti BD, Gause BL, Janik JE, Braman VM, Esseltine D, Wilson WH, Kaufman D, Wittes RE, Nadler LM, Urba WJ.
    Cancer J; 2000 Nov 15; 6(3):146-50. PubMed ID: 10882329
    [Abstract] [Full Text] [Related]

  • 26. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas.
    Kaku K, Inoue M, Fujii S, Ishida Y, Hiroshige Y, Shinohara K, Nakashima K, Matsumoto N, Kaneko T.
    Nihon Ketsueki Gakkai Zasshi; 1983 Jul 15; 46(4):940-6. PubMed ID: 6195877
    [No Abstract] [Full Text] [Related]

  • 27. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
    Palomera L, Azaceta G, Varo MJ, Soria J, Gutierrez M.
    Haematologica; 1998 Nov 15; 83(11):1045-6. PubMed ID: 9864929
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST, Miller TP.
    Curr Hematol Rep; 2004 Jan 15; 3(1):17-26. PubMed ID: 14695845
    [Abstract] [Full Text] [Related]

  • 32. [Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
    Uchida T, Sugimoto K, Koike M.
    Rinsho Ketsueki; 2009 Feb 15; 50(2):83-6. PubMed ID: 19265299
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Current status and new vistas in combination chemotherapy.
    Frei E.
    Mt Sinai J Med; 1985 Jun 01; 52(6):460-4. PubMed ID: 3875026
    [No Abstract] [Full Text] [Related]

  • 39. [Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
    Kaźmierczak M, Komarnicki M, Kroll R.
    Acta Haematol Pol; 1995 Jun 01; 26(3):311-3. PubMed ID: 8525778
    [Abstract] [Full Text] [Related]

  • 40. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B, Santos ES.
    Expert Rev Anticancer Ther; 2007 Mar 01; 7(3):257-73. PubMed ID: 17338647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.